Potent Antibacterial Profile of 5-Oxo-Imidazolines in the New Millennium by Nasare, Roshan D. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
125,000 140M
TOP 1%154
5,000
Chapter
Potent Antibacterial Profile of
5-Oxo-Imidazolines in the New
Millennium
Roshan D. Nasare, Mohammad Idrees, Satish S. Kola
and Rajendra S. Dongre
Abstract
Pharmaceutics and therapeutics industries enforced chemists to seek/discover
antibacterial novel heterocycles owing specific bioactivity and innate characteristics
significance. This chapter summarized potent antibacterial profile of 5-oxo-
imidazolines in the new millennium as an antibacterial against Gram-positive and
Gram-negative bacteria viz. B. thuringiensis, S. aureus, E. coli, and E. aerogenes is
presented in this chapter. 5-(H/Br benzofuran-2-yl)-1-phenyl 1H-pyrazole-3-
carbohydrazides are condensed with 4-(arylidene)-2 phenyloxazol-5(4H)-one in
acetic acid at elevated temperature to yield product 5-(H/Br benzofuran-2-yl)-N-
(4-arylidene-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-1-phenyl-1H-pyrazole-3-
carboxamides. Different substrates like 4-(arylidene)-2-phenyloxazol-5(4H)-one
allowed to react with benzaldehyde hippuric acid to yield 5-oxo-imidazolines/
5-oxo-4,5-dihydroimidazole. All synthesized 5-oxo-imidazolines were characterized
via elemental analysis and FT-IR, 1H-NMR and mass spectra techniques. All
5-oxo-imidazolines assayed in vitro for inherent antimicrobial activity at different
concentration against stated bacterial strains and compared with standard chloram-
phenicol. 5-Oxo-imidazolines (3a and 3c) with 125 μg/mL concentration showed
excellent antibacterial profile against Gram-positive bacteria, B. thuringiensis, while
other derivatives at different concentrations showed moderate antibacterial activity
against Gram-positive bacteria, S. aureus and B. thuringiensis. Gram-negative bacte-
ria like E. coli and E. aerogenes are tested at higher concentration (1000, 500, and
125 μg/mL) and found good-to-moderate antibacterial activity. Tested products
found non-active against E. aerogenes for 125, 61, and 31 μg/mL concentration also
inactive at conc. 31 μg/mL against E. coli.
Keywords: antibacterial, Gram positive/negative, B. thuringiensis, S. aureus, E. coli,
E. aerogenes, 5-oxo-imidazoline, azlactones, medicinal
1. Introduction
Imidazole is a planer five-member ring with molecular formula C3N2H4,
containing three carbon atoms and two nitrogen atoms in 1 and 3 skeletal positions
as depicted in Figure 1. This is an aromatic heterocyclic ring that’s classified as a
diazole family owing non-adjacent nitrogens in its skeleton.
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Assorted naturally occurring alkaloids own this imidazole moiety as vital bio-
logical building blocks viz; histidine and related hormone histamine. Various
synthetic drugs are based on imidazole rings like antifungal, antibiotics:
nitroimidazole and sedative: midazolam etc. Oxo-imidazoline derivatives are keto-
dihydroimidazoles too, known as imidazolinone a five member ring system having
2-nitrogen situated at 1 and 3-positions and ─C═O at various positions like 2, 4 and
5 of ring. Three possible isomers of imidazolinone observed based on position of
C═O substituent at skeleton namely: 2-oxo-imidazoline (2), 4-oxo-imidazoline (3)
and 5-oxo-imidazoline (4).
5-Oxo-4,5-dihydroimidazole derivative is called as 5-oxo-imidazoline, unsatu-
rated system, in fact nitrogen analogues of azlactone/oxazolone can be converted
into amino acids [1, 2] and also employed active pharmaceutical ingredient/API
component in drugs [3]. 5-Oxo-imidazoline holds biological as well as chemical
aspects for a long time; among the various heterocycles, it is preferred due to its
wide antimicrobial profile. Certain imidazolines are useful intermediates in synthe-
sis of many natural products as well as common building blocks in many biologi-
cally active moieties [4].
Figure 1.
Certain potent antibacterial profile of 5-oxo-imidazolines in the new millennium [5–16].
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Biological importance of 5-oxo-imidazoline: Literature survey indicated that
the synthetic drugs/molecules incorporated with 5-oxo-imidazoline found to owe
assorted biological/clinical significance and wide range of pharmacological activities
as mention below:
Solankee et al. [17] synthesized some 5-imidazolinones (5) and evaluated as
anticancer agent.
Mistry et al. [18] have synthesized imidazolinone (6) and studied antibacterial,
antifungal activities.
Kathrotiya et al. [19] and co-workers reported a series of some new quinoline
based imidazole-5-one derivatives (7) and evaluated them as antibacterial and
antifungal agent.
Desai et al. [20] also reported the synthesis of 5-oxo-imidazole amides derivatives
including quinoline unit (8) and assessed their antibacterial and antifungal agent.
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Mohammad and coworkers [21] have prepared some new imidazolinones and
investigated their antimicrobial activities. Khan et al. [22] have also reported
antibacterial and fungicidal activity of 5-oxo-imidazolines. Herbicidal activity of
imidazolinone derivatives have been reported by Andreani et al. [23]. Moreover
Zhou et al. [24] and Pai et al. [25] have reported anticancer active analogues of
5-oxo-imidazolines. Imidazolinone derivatives which possess antifungal activities
have been reported by Shah et al. [26]. Some new 5-oxo-imidazolines as antimicro-
bial agents have been investigated by Patel et al. [27]. Rao [28] have prepared
substituted imidazolone derivatives and reported their pharmaceutical use as
inhibitors of p38 MAP Kinase and ERK-2 inhibitors. Xue et al. [29] have
synthesized and evaluated imidazole-2-one derivatives as potential antitumor
agents. Parekh and co-workers [30] have synthesized 5-oxo-imidazolines as novel
bioactive compounds derived from benzimidazole. Kanjaria and co-workers [31]
have described imidazolinones as potential antimicrobial agents. Joshi et al. [3]
have synthesized imidazolinones as potent anticonvulsant agents. Acharya et al.
[32] tested the imidazolinone (9) having quinolone nucleus for their antibacterial
activity toward Gram-positive and Gram-negative bacteria and antifungal activity
toward Aspergillus niger at a concentration of 40 μg, they found active against
microorganism.
In view of potent antimicrobial and other pharmacological activities
exhibited by 5-oxo-imidazolines, a variety of novel imidazolone analogs (3a-g)
were synthesized by the condensation of different substituted oxazolines (2a-g)
with hetero-aromatic amines (1a-b). All the synthesized compounds were
screened for in vitro activities against a panel of Gram-positive and Gram-negative
bacteria.
2. Materials and method
Melting points of all synthesized compounds were recorded in open capillary
tube and are uncorrected. IR was recorded on a Shimadzu IR Spectrophotometer in
KBr pellets. 1H-NMR recorded on a Bruker AM 400 model (400 MHz) using
tetramethylsilane (TMS) as an internal reference and DMSO-d6 as solvent. Chem-
ical shifts are given in parts per million (ppm). Positive-ion electrospray ionization
(ESI) mass spectra were obtained with a Waters MicromassQ–TOF Micro, Mass
Spectrophotometer. Elemental analysis was done on Vario EL III Elemental
Analyzer, all compounds showed satisfactory elemental analysis. Reactions were
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monitored by E. Merck TLC aluminum sheet silica gel 60F254 and seen spot in UV
light and iodine chamber.
3. Experimental
(I) Synthesis of benzoyl glycine [33]: A solution of glycine (0.33 mol) in
10% NaOH (250 mL) of was prepared and benzoyl chloride (45 mL,
0.385 mol) was added to the above solution in portions. The mixture
was shaken vigorously after each addition until all the chlorides have been
reacted. The mixture was cooled by adding few grams of crushed ice and
was acidified by adding conc. HCl slowly with constant stirring. The
resulting crystalline precipitate of benzoyl glycine was filtered and
washed with cold water and dried. The solid was treated with hot CCl4
in order to remove benzoic acid. The dried product was recrystallized
with boiling water.
(II) Synthesis of 4-(arylidene)-2-phenyloxazol-5(4H)-ones [33] (2a-g):
Benzoyl glycine (0.0476 mmol), aryl aldehydes (0.0476 mol), acetic
anhydride (14 mL, 0.146 mmol) and anhydrous sodium acetate
(0.0476 mmol) were placed in a 250 mL conical flask. It was heated
on electric hot plate with constant shaking until the mixture liquefies
completely. Then it was refluxed for 2 h on water bath. Then
ethanol (10 mL) was added and mixture was allowed to stand
overnight. The crystalline precipitate was filtered, washed with ice-cold
alcohol and boiling water. The product was dried and recrystallized using
benzene.
(III) Preparation of 5-(5-H/Br benzofuran-2-yl)-1-phenyl-1H-pyrazole
carbohydrazide (1a-b): Synthesis of (5-(5-H/Br benzofuran-2-yl)-1-
phenyl-1H-pyrazole-3-carbohydrazides (1a-b) were prepared in laboratory
in quantitative yield according to reference method [34].
(IV) General procedure for the synthesis of 5-(5-H/Br benzofuran-2-yl)-N-
(4-arylidene-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-1-phenyl-1H-
pyrazole-3 carboxamide (3a-g): To a mixture of 4-benzylidene-2-
phenyloxazol-5(4H)-one, 2a (0.002 mol) and 5-(benzofuran-2-yl)-1-
phenyl-1H-pyrazole-3-carbohydrazide 1a (0.002 mol), acetic acid (20 mL)
were added and the contents were refluxed for 9 h. Resulting mass was
poured onto crushed ice, filtered and the product was recrystallized from
ethanol to give 3a.
Similarly, other 5-(bromobenzofuran-2-yl)-N-(4-arylidene-5-oxo-2-phenyl-4,5-
dihydro imidazole-1-yl)-1-phenyl-1H-pyrazole-3-carboxamide 3b-g were synthe-
sized from 1b and 2b-g by extending the same procedure followed for 3a.
• Reaction scheme:
See Figures 2 and 3.
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4. Results and discussion
4.1 Spectral, elemental and physical data of synthesized compounds
5-(Benzofuran-2-yl)-N-(4-benzylidene-5-oxo-2-phenyl-4,5-
dihydroimidazol-1-yl)-1-phenyl-1H-pyrazole-3-carboxamide (3a): Yellow crys-
talline solid; mp. 200–204°C; yield, 90%.
IR (KBr, v max in cm1): 3197 (NH), 3062 (ArH), 1793, 1719 (C═O imidazole),
1597, 1525, 1496, 1448, (C═C), 1207, 1292, 1028 (C─O─C), 1164 (C─N─C stretch),
1640 (C═O in amide group), 1525 (C═N), 1110 (C─N).
1H-NMR (DMSO-d6): δ (ppm) 6.53 (s, 1H, C4 of pyrazole ring), 11.65 (s, 1H,
NH of amide group), 7.22–8.37 (m, 21H, ArH + benzofuran ring).
MS: m/z550 [M+H]+, 551 [M+2]+, 572 [M+Na]+, 573 [(M+H)+Na]+.
Elemental analysis: Calcd: for C34H23N5O3; calculated: C, 74.30; H, 4.22; N,
12.74; found: C, 74.16; H, 4.05; N, 12.37.
Figure 3.
3D representation of 5-(benzofuran-2-yl)-N-(4-benzylidene-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-1-
phenyl-1H-pyrazole-3-carboxamide (compound 3a).
Figure 2.
Reaction scheme for 5-oxo-imidazoline derivatives.
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4-(4-Methoxybenzylidene)-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-5-
(5-bromo benzofuran-2-yl)-1-phenyl-1H-pyrazole-3-carboxamide (3b): Yellow
crystalline solid; recrystallization solvent, Ethanol; mp. 132–135°C; yield, 78%; IR
(KBr, v max in cm1): 3315 (NH), 3063 (ArH), 1779, 1720 (C═O imidazole), 1502,
1438 (C═C), 1257, 998 (C─O─C), 1159 (C─N─C stretch), 1649 (C═O in amide
group), 1595 (C═N), 1106 (C─N). Elemental anal. calcd: for C35H24BrN5O4; calcu-
lated: N, 10.64; found: N, 10.03.
4-(2-Chlorobenzylidene)-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-5-(5-
bromobenzofuran-2-yl)-1-phenyl-1H-pyrazole-3-carboxamide (3c): Yellow
crystalline solid; re-crystallization solvent, ethanol; mp. 155–158°C; yield, 82%; IR
(KBr, v max in cm1): 3417 (NH), 1786, 1715 (C═O imidazole), 1501, 1433 (C═C),
1243, 1060 (C─O─C), 1155 (C─N─C stretch), 1643 (C═O in amide group), 1595
(C═N), 1106 (C─N). Elemental anal. calcd: for C34H21BrClN5O3; calculated: N,
10.56; found: N, 10.11.
5-(5-Bromobenzofuran-2-yl)-N-(4-(naphthalen-1-ylmethylene)-5-oxo-2-
phenyl-4,5-dihydroimidazol-1-yl)-1-phenyl-1H-pyrazole-3-carboxamide (3d):
Yellow crystalline solid; recrystallization solvent, ethanol; mp. 136–138°C; yield,
76%; IR (KBr, v max in cm1): 3378 (NH), 3005 (ArH), 1778, (C═O imidazole),
1489, 1431 (C═C), 1236, 1069 (C─O─C), 1151 (C─N─C stretch), 1689 (C═O in
amide group), 1593 (C═N), 1151 (C─N). Elemental anal. calcd: for C38H24BrN5O3;
calculated: N, 10.32; found: N, 10.40.
4-(4-(Benzyloxy)benzylidene)-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-
5-(5 bromobenzofuran-2-yl)-1-phenyl-1H-pyrazole-3-carboxamide (3e):Yellow
crystalline solid; recrystallization solvent, ethanol; mp. 155–157°C; yield, 80%; IR
(KBr, v max in cm1): 3432 (NH), 3062, 2986 (ArH), 1786, 1716 (C═O imidazole),
1501, 1438 (C═C), 1249, 998 (C─O─C), 1160 (C─N─C stretch), 1642 (C═O in
amide group), 1595 (C═N), 1110 (C─N). Elemental anal. calcd: for C41H28BrN5O4;
calculated: N, 9.53; found: N, 9.07.
5-(5-Bromobenzofuran-2-yl)-N-(5-oxo-2-phenyl-4-((E)-3-phenylal-
lylidene)-4,5-dihydroimidazol-1-yl)-1-phenyl-1H-pyrazole-3-carboxamide
(3f): Yellow crystalline solid; recrystallization solvent, ethanol; mp. 158–160°C;
yield, 84%; IR (KBr, v max in cm1): 3342 (NH), 3034 (ArH), 1783 (C═O imidaz-
ole), 1493, 1439 (C═C), 1237, 1068 (C─O─C), 1158 (C─N─C stretch), 1627 (C═O
in amide group), 1597 (C═N), 1105 (C─N). Elemental anal. calcd: for
C36H24BrN5O3; calculated: N, 10.70; found: N, 10.25.
5-(5-Bromobenzofuran-2-yl)-N-(4-(furan-2-ylmethylene)-5-oxo-2-phenyl-
4,5-dihydroimidazol-1-yl)-1-phenyl-1H-pyrazole-3-carboxamide(3g): Yellow
crystalline solid; recrystallization solvent, ethanol; mp. 148–150°C; yield, 83%; IR
(KBr, v max in cm1): 3431 (NH), 3062(ArH), 1783 (C═O imidazole), 1496, 1450
(C═C), 1231, 1008 (C─O─C), 1153 (C─N─C stretch), 1641 (C═O in amide group),
1525 (C═N in imidazole), 1079 (C─N). Elemental anal. calcd: for C32H20BrN5O4;
calculated: N, 11.32; found: N, 10.96.
4.2 Common examination of the product
The newly synthesized compounds are soluble in following solvents which are
listed in table also identification of newly synthesized compounds has been further
confirmed by Lassaigne’s test for nitrogen, all compound gives positive test. Table 1
represents the structure of all derivatives along with solubility solvent and
Lassaigne’s test.
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Sr. no. Structure and compound code Solubility Lassaigne’s test for nitrogen
1. 1,4-Dioxane, DMSO, THF Prussian blue coloration
2. 1,4-Dioxane, DMSO, THF Prussian blue coloration
3. 1,4-Dioxane, DMSO, THF Prussian blue coloration
4. 1,4-Dioxane, DMSO, THF Prussian blue coloration
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5. 1,4-Dioxane, DMSO, THF Prussian blue coloration
6. 1,4-Dioxane, DMSO, THF Prussian blue coloration
7. 1,4-Dioxane, DMSO, THF Prussian blue coloration
Table 1.
Analysis characteristics.
9 P
oten
t
A
n
tib
a
cteria
l
P
rofile
of
5
-O
x
o-Im
id
a
zolin
es
in
th
e
N
ew
M
illen
n
iu
m
D
O
I:h
ttp
://d
x
.d
oi.org/10
.5772
/in
tech
op
en
.81269
4.3 Physico-chemical characterization
The synthesis of the novel compounds 3a-g is described in the reaction schemes.
Purity of the compounds was monitored by TLC technique. The structures of the
newly synthesized compounds were confirmed using chemical transformation
reaction, physical data, elemental analysis and different spectroscopic techniques
such as IR, 1H NMR and mass. The synthesis of the starting compound, 5-(5-H/Br
benzofuran-2-yl)-1-phenyl-1H-pyrazole-3-carbohydrazides (1a-b) and 4-
(arylidene)-2-phenyloxazol-5(4H)-ones (2a-g) achieved in quantitative yields
according to the reference method. The reaction of 1a-b with 2a-g (4-(arylidene)-
2-phenyloxazol-5(4H)-ones) in acetic acid solvent yields compounds 3a-g.
IR spectrum of this 3a showed absorption bands at 3197 cm1 due to ─NH
stretching, disappearance of absorption band due to ─NH2 stretching and two
absorption bands at 1719 and 1640 cm1 for two carbonyl groups of imidazoline and
aryl amide respectively indicated that 4-(arylidene)-2-phenyloxazol-5(4H)-ones
has condensed with 5-(5-H/Br benzofuran-2-yl)-1-phenyl-1H-pyrazole-3-
carbohydrazides to form 3a. In addition, 1H NMR spectrum of 3a showed singlet at
δ 10.65 ppm for ─NH group and disappearance of signal due to ─NH2 group in the
synthesized compound 3a which is expected in carbohydrazide 1a and also
exhibited multiplet at δ 7.22–8.37 ppm due to 21 aromatic protons is in consistent
with aromatic protons of 3a. The % of elements in 3a was C 74.16, H 4.05 and N
12.37, while its mass spectrum shows molecular ion peaks at m/z 550 [M+H]+, 551
[M+2]+, 572 [M+Na]+, 573 [(M+H)+Na].+ which is in good agreement with the
proposed structure and molecular formula C34H23N5O3.
Similarly other imidazolinones (3b-g) were also identified on the basis of chem-
ical transformation reaction, physical data, IR and elemental detection. IR spectra of
each compound showed characteristics absorption bands for ─NH stretching and
disappearance of absorption band due to ─NH2 stretching, also showed
corresponding band for carbonyl group. Elemental analysis was carried for nitrogen
and sulfur of all compounds is found to be in good agreement with the calculated
values.
4.4 Antimicrobial activity/profile
Antimicrobial activity means activity of any agent or drug against microbial
organism. Microbial organism includes bacteria, viruses, fungi and protozoa. On the
basis of their activity against specific microbial organism they termed as like
antibacterial (against bacteria) that means they are capable to inhibit the growth of
bacteria or to kill the bacteria. Other term is antifungal (against fungi), antiviral
(against virus), antiprotozoal (against protozoa). Heterocyclic entities possess dif-
ferent antimicrobial activity. Activity changes by changing structural unit. It is very
interesting thing to check out antimicrobial activity of newly synthesized com-
pound. We carried out antibacterial activity of the novel compound (Figure 4).
4.5 Potent antibacterial/inhibition profile of 5-oxo-imidazolines (at different
concentration) by agar disc-diffusion method
Test solutions were prepared with known weight of compound in DMSO and
half diluted suitably to give the resultant concentration of 31–1000 μg/mL [35].
Whatman No. 1 sterile filter paper discs (6 mm) were impregnated with solution
and allowed to dry at room temperature. In-vitro antibacterial activity was deter-
mined by using Mueller Hinton Agar obtained from Himedia Ltd., Mumbai. Petri
plates were prepared by pouring 10 mL of Mueller Hinton Agar for bacteria
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containing microbial culture was allowed to solidify. The discs were then applied
and the plates were incubated at 37°C for 24 h (bacteria) and the inhibition zone
was measured as diameter in four directions and expressed as mean. The results
were compared using chloramphenicol as a standard antibacterial agent. The
results of antibacterial activity (i.e. zone of inhibition in mm) are given in the
Tables 2 and 3.
4.6 Inhibition profile zone for Gram-positive bacterial strains of tested
compound-3a-g
The synthesized compounds 3a-g were screened for their in vitro antimicrobial
activity using agar disc-diffusion method against two Gram-positive bacterial
Figure 4.
Antibacterial drug mechanism in cell wall of microbe. Source: Google image.
Zone of inhibition (mm)
Gram-positive bacteria
B. thuringiensis S. aureus
Compd. code Conc. (μg/mL) Conc. (μg/mL)
1000 500 250 125 63 31 1000 500 250 125 63 31
3a 15 14 12 18 12 10 14 12 16 12 18 15
3b 16 15 11 16 9 9 16 11 11 8 12 —
3c 14 15 12 17 11 8 16 14 16 11 14 13
3d 16 13 12 14 8 — 13 12 14 10 12 11
3e 13 11 13 12 11 — 14 13 13 10 11 10
3f 14 14 11 10 10 8 13 12 10 — 9 —
3 g 17 16 13 11 12 10 15 15 14 17 9 7
Std. drug 22 20 21 16 15 16 26 30 27 21 18 20
Standard drug: chloramphenicol.
Bold value indicates activity of tested compound is equal or high than standard drug.
Table 2.
Antibacterial activity of 3a-g.
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strains such as B. thuringiensis, S. aureus. Chloramphenicol was used as standard
drug for bacteria. According to antibacterial data obtained the test compounds 3a–c
at 125 μg/mL conc. showed excellent activity i.e. equal or higher than the standard
drug and other derivatives viz. 3d–g at 125 μg/mL conc. showed good inhibitory
activity against B. thuringiensis. At conc. 1000, 500, and 250 μg/mL imidazolinone
derivatives 3a-g showed good to moderate activity against B. thuringiensis, whereas
3d and 3e are found to be inactive at 31 μg/mL against Gram-positive bacteria,
B. thuringiensis. In case of S. aureus 3a exhibit with excellent activity at 63 μg/mL
conc. While at 1000, 500, 250 μg/mL concentrations 3a-g possesses good to
moderate activity. Whereas 3b & 3f are found to be inactive at 31 μg/mL also 3f
found to be inactive at 125 μg/mL against S. aureus. Obtained results of in-vitro
antimicrobial activities of 3a-h are summarized in Table 2.
12
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4.7 Inhibition profile zone for Gram-negative bacterial strains of tested
compound-3a-g
The synthesized compounds 3a-g were screened for their in vitro antimicrobial
activity using agar disc-diffusion method against two Gram-negative bacterial
strains such as E. coli, E. aerogenes. Chloramphenicol was used as standard drug for
bacteria. According to antibacterial data obtained the test compounds 3a-g pos-
sesses good to moderate activity at higher concentrations, i.e. 1000, 500, 250 and
125 μg/mL against Gram-negative bacteria E. coli. At conc. 63 μg/mL 3a-g showed
good activity while 3b& 3e found to be inactive against E. coli. At conc. 31 μg/mL
3d, 3f & 3g showed moderate activity whereas 3a, 3b, 3c & 3e found to be inactive
against E. coli. In case of E. aerogenes, tested compounds showed moderate activity
at higher concentrations while poor activity at lower concentrations. At conc.
125 μg/mL 3a, 3d, 3e and at 63 μg/mL 3a, 3b, 3d, 3e, 3f found to be inactive. All the
compounds were inactive at a concentration of 31 μg/mL against E. aerogenes.
Obtained results of in-vitro antimicrobial activities of synthesized 5-oxo-
imidazolines (3a-g) are summarized in Table 3.
Zone of inhibition (mm)
Gram-negative bacteria
E. coli E. aerogenes
Compd. code Conc. (μg/mL) Conc. (μg/mL)
1000 500 250 125 63 31 1000 500 250 125 63 31
3a 14 10 12 15 12 — 10 12 10 — — —
3b 11 11 9 12 — — 12 11 13 8 — —
3c 18 14 11 13 8 — 13 13 12 10 8 —
3d 13 12 10 12 10 8 10 9 10 — — —
3e 15 12 8 10 — — 9 10 11 — — —
3f 14 10 12 13 9 9 11 12 8 9 — —
3 g 15 13 12 14 10 8 12 10 9 7 8 —
Std. drug 24 20 18 17 17 21 16 16 17 16 15 15
Standard drug: chloramphenicol.
Bold value indicates activity of tested compound is equal or high than standard drug.
Table 3.
Antibacterial activity of 5-oxo-imidazoline compounds (3a-g).
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4.8 Mechanism of inhibition/prohibition
Gram-negative bacteria habitually owe low susceptibility as outer membrane of
their cell wall not gets blocked/penetrated by drugs easily and factors like amount of
peptidoglycan, receptors, and lipids availability, nature of cross-linking, autolytic
enzymes activity greatly influence the bio-activity, permeation, and incorporation
of the antibacterial drugs. 5-Oxo-imidazoles showed their specificity for polysac-
charides, thats present in the outer membrane of many Gram-negative bacteria and
so acted selectively toxic for series of B. thuringiensis, S. aureus bacteria. Mechanis-
tically, once alliance with lipopolysaccharide substrate in outer membrane of
B. thuringiensis, S. aureus bacteria, synthesized imidazolinone: potent antibacterial
agent changes their membrane structure, thus enhances permeability and
disruption of osmotic balance that ultimately results higher physiological effects.
Figure 5.
Inhibition profile zone for four different bacterial strains of tested compound-3a (at different concentration).
14
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Also, alteration like discharge of molecules from interior of B. thuringiensis, S. aureus
bacterial cell inhibits respiration and increased water uptake may leads to cell death.
Gram-positive bacteria own too thick cell wall and deny easy access of 5-oxo-
imidazoles via their bacterial cell membrane, thus less effective on E. coli and E.
aerogenes series of bacteria. The inhibition profile zone for four different bacterial
strains of tested compound-3a (at different concentration) 5-oxo-imidazoline com-
pounds are shown in Figure 5.
5. Conclusion
Assorted antibacterial agents own certain limitations viz.; resistance/potency,
vast types and numbers own different structures besides slightly dissimilar pattern
of activity which made it necessary to discover/explore the existing class and func-
tions of almost all the antibacterial agents. Thus, futuristic pathogenic bacterial
infections/diseases can be easily cured via promising antibacterial chemotherapeu-
tic agents derive from 5-oxo-Imidazole skeleton. Pursued chapter described
antibacterial resistance of 5-oxo-imidazoles mostly against Gram-positive series like
B. thuringiensis, S. aureus. 5-Oxo-imidazoles can act onto simple one-celled bacterial
organism that could kill, inhibit, or at least slower down their growth and ultimately
can inhibit concern diseases/infections. This chapter focused on helping futuristic
researchers, clinicians, and academicians involved in synthesizing and
corresponding biological screening of innate activity of certain novel imidazolinone
heterocycles. These synthesized 5-oxo-imidazoles restrain potent antibacterial
activity may own prospective different therapeutic behavior if developed as
advanced drug moiety. Therefore, chapter focus on the basis of chemical structure
of 5-oxo-imidazoles. Gram-positive and Gram-negative bacteria showed varied
response/susceptibility toward 5-oxo-imidazoles.
Targeted 5-oxo-imidazolines (3a-g) a class of imidazolinones are successfully
synthesized in good yields and purity checked by physical, analytical and spectral
data. Antibacterial screening of 5-oxo-imidazolines (3a-g) exhibited a potent bac-
tericidal. Thus, 5-oxo-imidazolines could be powerfully stimulates major advances
in remarkable significant chemotherapeutics in medicine, biology and pharmacy.
Overall these imidazolinones disturb macromolecules like cytoplasmic membrane
covering cytoplasm which acts selective barrier to control internal composition of
cell. 5-Oxo-imidazoles in particular interrupted such functional roles of cytoplasmic
membrane and ionic outflow that resulted cell destruction/death. Synthesized
potent bioactive 5-oxo-imidazoles may open new possibilities in the successful
treatment of several diseases due to promising antibacterial profile. So, ample scope
exists in further research of imidazolinones especially innate selectivity of 5-oxo-
imidazoles needs to carry out their chemotherapy as potent antibacterial aims to
target cell membrane of range of Gram-negative bacteria as to derive novel drugs of
new millennium.
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